TY - JOUR
T1 - A deep intronic splice mutation of STAT3 underlies hyper IgE syndrome by negative dominance
AU - Khourieh, Joëlle
AU - Rao, Geetha
AU - Habib, Tanwir
AU - Avery, Danielle T.
AU - Lefèvre-Utile, Alain
AU - Chandesris, Marie Olivia
AU - Belkadi, Aziz
AU - Chrabieh, Maya
AU - Alwaseem, Hanan
AU - Grandin, Virginie
AU - Sarrot-Reynauld, Françoise
AU - Sénéchal, Agathe
AU - Lortholary, Olivier
AU - Kong, Xiao Fei
AU - Boisson-Dupuis, Stéphanie
AU - Picard, Capucine
AU - Puel, Anne
AU - Béziat, Vivien
AU - Zhang, Qian
AU - Abel, Laurent
AU - Molina, Henrik
AU - Marr, Nico
AU - Tangye, Stuart G.
AU - Casanova, Jean Laurent
AU - Boissona, Bertrand
N1 - Funding Information:
We thank the patients and their families for participating in this study. We thank James E. Darnell and Claudia Mertens for providing the STAT3-deficient A4 cell line. We thank the members of the laboratory, especially David Hum for his technical assistance and Lahouari Amar, Yelena Nemirovskaya, Dominick Papandrea, Mark Woollett, Céline Desvallées, and Cécile Patissier for administrative assistance; Alicia Fernandes from the Vecteurs Viraux et Transfert de Gènes (Platform VVTG), Necker Hospital, for generating immortalized B cell lines for the patients; and members of Sidra Medicine's genomics core facility team for their contribution to the mRNA-Seq library preparation and Illumina sequencing. This work was supported by the St. Giles Foundation, the Rockefeller University, INSERM, Paris Descartes University, HHMI, Sidra Medicine, the Job Research Foundation, and the French National Research Agency (ANR) under the "PNEUMOPID" project (Grant ANR 14-CE15-0009-01). J.K. was supported by the ANR (Grant ANR-14-CE15-0009-01) and the Imagine Institute (Imagine 4th year PhD scholarship). V.B. was supported by the ANR (Grant NKIRP-ANR-13-PDOC- 0025-01). S.G.T. is supported by the National Health and Medical Research Council of Australia and the Job Research Foundation.
Funding Information:
ACKNOWLEDGMENTS. We thank the patients and their families for participating in this study. We thank James E. Darnell and Claudia Mertens for providing the STAT3-deficient A4 cell line. We thank the members of the laboratory, especially David Hum for his technical assistance and Lahouari Amar, Yelena Nemirovskaya, Dominick Papandrea, Mark Woollett, Céline Desvallées, and Cécile Patissier for administrative assistance; Alicia Fernandes from the Vecteurs Viraux et Transfert de Gènes (Platform VVTG), Necker Hospital, for generating immortalized B cell lines for the patients; and members of Sidra Medicine’s genomics core facility team for their contribution to the mRNA-Seq library preparation and Illumina sequencing. This work was supported by the St. Giles Foundation, the Rockefeller University, INSERM, Paris Descartes University, HHMI, Sidra Medicine, the Job Research Foundation, and the French National Research Agency (ANR) under the “PNEUMOPID” project (Grant ANR 14-CE15-0009-01). J.K. was supported by the ANR (Grant ANR-14-CE15-0009-01) and the Imagine Institute (Imagine 4th year PhD scholarship). V.B. was supported by the ANR (Grant NKIRP-ANR-13-PDOC-0025-01). S.G.T. is supported by the National Health and Medical Research Council of Australia and the Job Research Foundation.
Publisher Copyright:
© 2019 National Academy of Sciences. All rights reserved.
PY - 2019/8/13
Y1 - 2019/8/13
N2 - Heterozygous in-frame mutations in coding regions of human STAT3 underlie the only known autosomal dominant form of hyper IgE syndrome (AD HIES). About 5% of familial cases remain unexplained. The mutant proteins are loss-of-function and dominant-negative when tested following overproduction in recipient cells. However, the production of mutant proteins has not been detected and quantified in the cells of heterozygous patients. We report a deep intronic heterozygous STAT3 mutation, c.1282-89C>T, in 7 relatives with AD HIES. This mutation creates a new exon in the STAT3 complementary DNA, which, when overexpressed, generates a mutant STAT3 protein (D427ins17) that is loss-of-function and dominant-negative in terms of tyrosine phosphorylation, DNA binding, and transcriptional activity. In immortalized B cells from these patients, the D427ins17 protein was 2 kDa larger and 4-fold less abundant than wild-type STAT3, on mass spectrometry. The patients' primary B and T lymphocytes responded poorly to STAT3-dependent cytokines. These findings are reminiscent of the impaired responses of leukocytes from other patients with AD HIES due to typical STAT3 coding mutations, providing further evidence for the dominance of the mutant intronic allele. These findings highlight the importance of sequencing STAT3 introns in patients with HIES without candidate variants in coding regions and essential splice sites. They also show that AD HIES-causing STAT3 mutant alleles can be dominant-negative even if the encoded protein is produced in significantly smaller amounts than wild-type STAT3.
AB - Heterozygous in-frame mutations in coding regions of human STAT3 underlie the only known autosomal dominant form of hyper IgE syndrome (AD HIES). About 5% of familial cases remain unexplained. The mutant proteins are loss-of-function and dominant-negative when tested following overproduction in recipient cells. However, the production of mutant proteins has not been detected and quantified in the cells of heterozygous patients. We report a deep intronic heterozygous STAT3 mutation, c.1282-89C>T, in 7 relatives with AD HIES. This mutation creates a new exon in the STAT3 complementary DNA, which, when overexpressed, generates a mutant STAT3 protein (D427ins17) that is loss-of-function and dominant-negative in terms of tyrosine phosphorylation, DNA binding, and transcriptional activity. In immortalized B cells from these patients, the D427ins17 protein was 2 kDa larger and 4-fold less abundant than wild-type STAT3, on mass spectrometry. The patients' primary B and T lymphocytes responded poorly to STAT3-dependent cytokines. These findings are reminiscent of the impaired responses of leukocytes from other patients with AD HIES due to typical STAT3 coding mutations, providing further evidence for the dominance of the mutant intronic allele. These findings highlight the importance of sequencing STAT3 introns in patients with HIES without candidate variants in coding regions and essential splice sites. They also show that AD HIES-causing STAT3 mutant alleles can be dominant-negative even if the encoded protein is produced in significantly smaller amounts than wild-type STAT3.
KW - Dominant negative
KW - Hyper IgE syndrome
KW - Immunodeficiency
KW - Infectious diseases
KW - STAT3
UR - http://www.scopus.com/inward/record.url?scp=85071353049&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071353049&partnerID=8YFLogxK
U2 - 10.1073/pnas.1901409116
DO - 10.1073/pnas.1901409116
M3 - Article
C2 - 31346092
AN - SCOPUS:85071353049
SN - 0027-8424
VL - 116
SP - 16463
EP - 16472
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 33
ER -